What is Carfilzomib-lenalidomide-dexamethasone?

Category: Prescription Drugs


See also: Carfilzomib Lenalidomide

Carfilzomib-lenalidomide-dexamethasone is a regimen that may be used for the treatment of multiple myeloma. It includes carfilzomib and lenalidomide, anticancer agents, and dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 0
None 2

Commonly reported side effects and conditions associated with Carfilzomib-lenalidomide-dexamethasone

Side effect Patients
Tiredness 1


Based on patients currently taking Carfilzomib-lenalidomide-dexamethasone

Dosage Patients
every 12 weeks 1


Currently taking Carfilzomib-lenalidomide-dexamethasone

Duration Patients
2 - 5 years 1
Adherence Evaluations
Always 2
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0

What people switch to and from

Patients started taking Carfilzomib-lenalidomide-dexamethasone after stopping:

Treatment Patients
Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD) 1
Last updated:
There are no evaluations for Carfilzomib-lenalidomide-dexamethasone.